Keno Gutierrez is the founder of Brenig Therapeutics. Brenig Therapeutics has raised $65M in total funding. Latest round: Series A.
Keno Gutierrez is a General Partner at BioGeneration Ventures, an early-stage VC firm. BioGeneration Ventures co-led the seed round for Brenig Therapeutics in 2021 and participated in their $65 million Series A financing in July 2024. Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide